Market regulation · 22/07/2011
CPSC Exempts Powder Formulations of Colesevelam Hydrochloride and Sevelamer Carbonate from Child-Resistant Packaging Requirements
The Consumer Product Safety Commission is amending its child-resistant packaging rules to exempt powder formulations of two oral prescription drugs, colesevelam hydrochloride and sevelamer carbonate, due to their non-toxic nature and low risk of accidental ingestion by young children.
Original source language: Federal Register — Consumer Product Safety CommissionOpen original release →